Fidelity International
PRQR icon

Fidelity International’s ProQR Therapeutics PRQR Stock Holding History

Fidelity International’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-899,257
Closed -$669K – 862
2022
Q3 		$669K Sell
899,257
-158,834
-15% -$128K ﹤0.01% 737
2022
Q2 		$823K Sell
1,058,091
-47,002
-4% -$35K ﹤0.01% 731
2022
Q1 		$1M Buy
1,105,093
+81,268
+8% +$272K ﹤0.01% 736
2021
Q4 		$8.2M Sell
1,023,825
-181,935
-15% -$1.39M 0.01% 559
2021
Q3 		$10.1M Buy
1,205,760
+177,958
+17% +$1.16M 0.01% 535
2021
Q2 		$6.93M Buy
1,027,802
+370,340
+56% +$2.39M 0.01% 601
2021
Q1 		$4.35M Buy
657,462
+326,258
+99% +$1.67M ﹤0.01% 623
2020
Q4 		$1.39M Hold
331,204
– – ﹤0.01% 630
2020
Q3 		$1.59M Buy
331,204
+139,590
+73% +$730K ﹤0.01% 605
2020
Q2 		$1.17M Buy
191,614
+112,372
+142% +$607K ﹤0.01% 603
2020
Q1 		$435K Buy
79,242
+27,018
+52% +$207K ﹤0.01% 630
2019
Q4 		$518K Buy
52,224
+12,009
+30% +$93.5K ﹤0.01% 672
2019
Q3 		$232K Buy
+40,215
New +$321K ﹤0.01% 668

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Fidelity International's PRQR Position: Q4 2022 in Review

Fidelity International sold out of ProQR Therapeutics (PRQR) in Q4 2022, closing a stake of 899,257 shares — an estimated $669K sold.

Fidelity International first reported a position in PRQR in Q3 2019 and held it in 13 quarters. The position peaked at $10.1M in Q3 2021. 46 funds tracked by Wall St. Rank hold PRQR as of Q4 2022.

  • Fidelity International reported no remaining ProQR Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Fidelity International sold 899,257 ProQR Therapeutics shares in Q4 2022, an estimated $669K.
  • Fidelity International first reported a position in ProQR Therapeutics in Q3 2019 and held it in 13 quarters.
  • Fidelity International's ProQR Therapeutics position peaked at $10.1M in Q3 2021.
  • 46 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2022.

Based on Fidelity International's 13F filing for Q4 2022, filed 13 Feb 2023.